Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel

Rhea-AI Summary

Inspira Technologies (Nasdaq: IINN) announced its participation at the annual iECOs Conference in Herzliya, Israel, on June 18, 2024.

The company will showcase the INSPIRA™ ART100 System, which recently received 510(k) clearance from the U.S. FDA and is pending approval from Israel's AMAR.

Inspira's R&D team will be available to discuss their advanced life support solutions and other technologies in development.

For meetings, attendees can contact the company via info@inspira02.com.

Positive

• INSPIRA™ ART100 System received 510(k) clearance from the U.S. FDA.
• Pending approval from AMAR, Israel's Ministry of Health.
• Showcasing advanced life support solutions at a major international conference.
• Direct engagement opportunities with R&D team for potential investors and partners.

Negative

• Approval from AMAR is still pending, creating uncertainty.
• No financial data or revenue projections provided in the announcement.
• The PR lacks information on commercial launch timelines or market strategy.

RA'ANANA, Israel, June 17, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce today that the Company will present at the annual iECOs Conference in Herzliya, Israel on June 18th, 2024.

The Company will present the INSPIRA™ ART100 System, recently 510(k) U.S. Food and Drug Administration-cleared, and which is pending approval from AMAR, the medical device division of the Israeli Ministry of Health. In addition, the Inspira Technologies research and development  team will be available at its booth at the conference to answer questions about its technologies and products currently in development. To schedule a meeting with the Company, please contact: info@inspira02.com

About iECOs

iECOs, known as the Israeli ECMO Society, is a medical organization for medical professionals in the fields of ICU medicine including pediatrics, cardiac medicine and surgery, heart-lung specialists, emergency medicine and heart failure to share knowledge and professional experiences, to improve and promote extracorporeal oxygenation education and medical practice.   

About Inspira Technologies OXY B.H.N. Ltd.

Inspira™ Technologies is an innovative medical technology company in the life support arena. The INSPIRA™ ART (Gen 2), also known as the INSPIRA™ ART500, shall include the Company's Adaptive Blood Oxygenation technology and is being designed to continuously measure the patient's blood parameters in real-time, delivering needed oxygen volume straight into the blood. By elevating patient oxygen saturation levels in minutes, this technology potentially allows patients to remain awake during treatment and therefore may enable patients to be treated in and beyond intensive care units, reducing the need for mechanical ventilation systems that requires intubation and medically induced coma.

The Company received FDA 510(k) clearance for its INSPIRA ART100, a Cardiopulmonary Bypass System.

The Company's other products, including the INSPIRA ART (Gen 2) and HYLA™ blood sensor, have not yet been tested or used in humans and have not been approved by any regulatory entity.

For more information, please visit our corporate website: https://inspira-technologies.com 

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the prospective exhibition of the INSPIRA™ ART100 system at the event, its pending regulatory approval from AMAR, and the potential benefits of its products. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2023 filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website, http://www.sec.gov 

For more details:
Public Relations Manager
Adi Shmueli
Inspira Technologies
info@inspirao2.com
+972-9-9664485

Copyright © 2018-2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved.

Logo - https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/inspira-introduces-advanced-life-support-solutions-to-key-international-leaders-at-the-annual-iecos-conference-in-israel-302174164.html

SOURCE Inspira Technologies

FAQ

What did Inspira Technologies announce on June 17, 2024?

Inspira Technologies announced its presentation at the iECOs Conference on June 18, 2024, featuring the INSPIRA™ ART100 System.

What is the INSPIRA™ ART100 System?

The INSPIRA™ ART100 System is a medical device recently cleared by the U.S. FDA under 510(k) and is pending approval from Israel's AMAR.

When and where will Inspira Technologies present its new system?

Inspira Technologies will present the INSPIRA™ ART100 System at the iECOs Conference in Herzliya, Israel, on June 18, 2024.

How can attendees schedule a meeting with Inspira Technologies?

Attendees can schedule a meeting by contacting Inspira Technologies at info@inspira02.com.

What is the stock symbol for Inspira Technologies?

The stock symbol for Inspira Technologies is IINN.